| GRANDDAD | growth delay-aged facies-normal development-deficiency of subcutaneous fat [syndrome] |
|---|---|
| SC | conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia... |
| S/C | subcutaneous, sugar-coated [pill] |
| sc | subcutaneous |
| SCE | secretory carcinoma of the endometrium; sister chromatid exchange; split hand-cleft lip/palate ectod... |
| interferon type II | <chemical> The major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon (interferon type I) and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease. Pharmacological action: antineoplastic agent, antiviral agents. Chemical name: Interferon-gamma (human lymphocyte protein moiety reduced) (12 Dec 1998) |
|---|---|
| type II interferon | <chemical> The major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon (interferon type I) and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease. Pharmacological action: antineoplastic agent, antiviral agents. Chemical name: Interferon-gamma (human lymphocyte protein moiety reduced) (12 Dec 1998) |
| type I interferon | <chemical> Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (interferon-alpha and interferon-beta). Pharmacological action: antineoplastic agent, antiviral agents. (12 Dec 1998) |
| fibroblast interferon | <cytokine> One of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA. It is a cytokine with antiviral, antiproliferative, and immunomodulating activity. Synonym: fibroblast interferon. Pharmacological action: adjuvants, immunologic, antineoplastic agent, antiviral agents. Chemical name: Interferon-alphaB (human leukocyte protein moiety reduced) (12 Dec 1998) |
| leukocyte interferon | <cytokine> One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells when exposed to live or inactivated virus, double-stranded RNA, or bacterial products. It is the major interferon produced by virus-induced leukocyte cultures and, in addition to its pronounced antiviral activity, causes activation of NK cells. It is used experimentally in the treatment of hairy-cell leukaemia. A number of different subtypes exist that are elaborated by leukocytes in response to viral infection or stimulation with double-stranded RNA; IFN-alpha-2A and -2B are protein products made by recombinant DNA techniques and are used as antineoplastic agents. See: interferon-alpha 2a, interferon-alpha 2b Synonym: leukocyte interferon. Pharmacological action: antineoplastic agent, antiviral agent. (20 Sep 2002) |
| adrenal cortex injection | An obsolete treatment involving the parenteral administration of extract of the adrenal cortex; formerly used in treatment of Addison's disease. (05 Mar 2000) |
| bolus injection | <procedure> The injection of a drug (or drugs) in a high quantity (called a bolus) at once, the opposite of gradual administration (as in intravenous infusion). (18 Nov 1997) |
| regular insulin injection | A preparation that may contain 20, 40, 80, 100, or 500 USP insulin units per ml, although the trend is toward standardizing all insulin preparations at 100 units per ml; it is administered subcutaneously, occasionally intravenously, and has a rapid onset of action, has a brief duration (5 to 7 hours), and is compatible for mixing with long-acting insulin preparations; used in the treatment of diabetic acidosis and insulin coma. Synonym: regular insulin injection. (05 Mar 2000) |
| Ringer's injection | A sterile solution of sodium chloride, potassium chloride, and calcium chloride, containing in each 100 ml between 820 and 900 mg of sodium chloride, between 25 and 35 mg of potassium chloride, and between 30 and 37 mg of calcium chloride; used intravenously as a fluid and electrolyte replenisher. (05 Mar 2000) |
| water for injection | Water purified by distillation for the preparation of products for parenteral use. (05 Mar 2000) |
| collagen injection | Correction of superficial soft tissue deformities, acne scars, or age-related skin changes by injection (implantation) of collagen; bovine collagen preparations are commonly used. Prior intradermal testing is necessary to exclude hypersensitivity. (05 Mar 2000) |
| selective injection | Injection of contrast medium following selective catheterization of a branch artery or vein for angiography. (05 Mar 2000) |
| sensitizing injection | An injection that sensitises a person so that subsequent exposure to the antigen (allergen) evokes an allergic response. (05 Mar 2000) |
| hypodermic injection | The administration of a remedy in liquid form by injection into the subcutaneous tissues. Synonym: hypodermic. (05 Mar 2000) |
| neutral beam injection | <radiobiology> This is one of the fundamental plasma heating methods. A particle accelerator is used to create fast ion beams (the particle energies are on the order of 100 keV), the ion beam is then passed through a neutral gas region, where the ions neutralise via charge-exchange reactions with the neutral gas. The neutralised beam is then injected into a magnetically confined plasma. The neutral atoms are unaffected (not confined) by the magnetic field, but ionize as they penetrate into the plasma. The high-energy ions then transfer some of their energy to the plasma particles in repeated collisions, and heat the plasma. (09 Oct 1997) |